Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI Trial.

Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI Trial. [electronic resource] - JAMA Jan 1995 - 199-208 p. digital

Publication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, U.S. Gov't, P.H.S.

0098-7484


Aged
Cholesterol, HDL--blood
Double-Blind Method
Drug Administration Schedule
Endometrial Hyperplasia--chemically induced
Estrogen Replacement Therapy
Estrogens, Conjugated (USP)--administration & dosage
Female
Fibrinogen--drug effects
Glucose--metabolism
Heart Diseases--epidemiology
Humans
Insulin--blood
Medroxyprogesterone Acetate--administration & dosage
Middle Aged
Postmenopause--drug effects
Risk Factors
Systole--drug effects
Weight Gain